Furthermore, in vitro targeting efficiency results revealed that Bom-targeted nanomicelles have a strong affinity toward GRPR-positive cells, suggesting their potential as active targeting contrast agents for precise imaging in breast cancer diagnostics. This evidence concerns the gene GRHL2 and breast carcinoma.